TY - JOUR
T1 - Glaucomatous Visual Field Progression in the African Descent and Glaucoma Evaluation Study (ADAGES)
T2 - Eleven Years of Follow-up
AU - Melchior, Bruna
AU - Valenzuela, Ives A.
AU - De Moraes, C. Gustavo
AU - Paula, Jayter S.
AU - Fazio, Massimo A.
AU - Girkin, Christopher A.
AU - Proudfoot, James
AU - Cioffi, George A.
AU - Weinreb, Robert N.
AU - Zangwill, Linda M.
AU - Liebmann, Jeffrey M.
N1 - Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/7
Y1 - 2022/7
N2 - PURPOSE: To compare the rates of visual field (VF) progression between individuals of Black and White race and to investigate whether treatment effects may help explain differences previously reported between racial groups. DESIGN: Multicenter prospective observational cohort study. METHODS: Participants were patients in referral tertiary care glaucoma clinics with open angle glaucoma. Eyes were excluded who had <5 VF tests and <2 years of follow-up or any disease that could affect the optic nerve or the VF. The VF mean deviation (MD) slopes over time (dB/y) were calculated with linear regression models. Socioeconomic variables, rates of glaucoma surgery, medications, treated intraocular pressure (IOP), and central corneal thickness (CCT) were investigated. RESULTS: A total of 516 eyes were included with a mean (95% CI) follow-up time of 11.0 (range, 10.5-11.5) years and 15.0 (range, 14.1-15.8) visits. Participants of Black race were significantly younger (59.7 vs 66.9 years, P <.01) than those of White race. The mean CCT and socioeconomic variables were similar between Black and White groups (P = 0.20 and P =.56, respectively), as were treatment with topical medications (P =.90) and the rate of VF MD change (−0.24 [−0.31 to −0.17] dB/year vs −0.32 [−0.36 to −0.27], P =.11), despite higher treated mean IOP (14.9 [14.5 to 15.4] vs 14.0 [13.6 to 14.4] mm Hg, P =.03) and fewer trabeculectomies (29.5% vs 50.0%, P <.01) in the Black race group. CONCLUSIONS: Rates of VF progression were similar despite higher treated IOP in the Black race group. Mitigation of health access disparities in this study may have equalized previously reported different rates of VF progression between racial groups.
AB - PURPOSE: To compare the rates of visual field (VF) progression between individuals of Black and White race and to investigate whether treatment effects may help explain differences previously reported between racial groups. DESIGN: Multicenter prospective observational cohort study. METHODS: Participants were patients in referral tertiary care glaucoma clinics with open angle glaucoma. Eyes were excluded who had <5 VF tests and <2 years of follow-up or any disease that could affect the optic nerve or the VF. The VF mean deviation (MD) slopes over time (dB/y) were calculated with linear regression models. Socioeconomic variables, rates of glaucoma surgery, medications, treated intraocular pressure (IOP), and central corneal thickness (CCT) were investigated. RESULTS: A total of 516 eyes were included with a mean (95% CI) follow-up time of 11.0 (range, 10.5-11.5) years and 15.0 (range, 14.1-15.8) visits. Participants of Black race were significantly younger (59.7 vs 66.9 years, P <.01) than those of White race. The mean CCT and socioeconomic variables were similar between Black and White groups (P = 0.20 and P =.56, respectively), as were treatment with topical medications (P =.90) and the rate of VF MD change (−0.24 [−0.31 to −0.17] dB/year vs −0.32 [−0.36 to −0.27], P =.11), despite higher treated mean IOP (14.9 [14.5 to 15.4] vs 14.0 [13.6 to 14.4] mm Hg, P =.03) and fewer trabeculectomies (29.5% vs 50.0%, P <.01) in the Black race group. CONCLUSIONS: Rates of VF progression were similar despite higher treated IOP in the Black race group. Mitigation of health access disparities in this study may have equalized previously reported different rates of VF progression between racial groups.
KW - Glaucoma
KW - visual field, race, socioeconomics
UR - http://www.scopus.com/inward/record.url?scp=85128196527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128196527&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2022.02.003
DO - 10.1016/j.ajo.2022.02.003
M3 - Article
C2 - 35172170
AN - SCOPUS:85128196527
SN - 0002-9394
VL - 239
SP - 122
EP - 129
JO - American journal of ophthalmology
JF - American journal of ophthalmology
ER -